Pankaj Singh

Activin receptor-like kinase-2 inhibitors (2024)

Pathania, Shelly; Singh, Pankaj Kumar

(A3 Vertaisarvioitu kirjan tai muun kokoomateoksen osa)

Identification of natural peptides from "PlantPepDB" database as anti-SARS-CoV-2 agents: A protein-protein docking approach (2023)

Phytomedicine plus : international journal of phytotherapy and phytopharmacology

Bhandu Priyanka, Verma Himanshu, Raju Baddipadige, Narendra Gera, Choudhary Shalki, Singh Manmeet, Singh Pankaj Kumar, Silakari Om

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach (2023)

International Journal of Biological Macromolecules

Narendra Gera, Raju Baddipadige, Verma Himanshu, Kumar Manoj, Jain Subheet Kumar, Tung Gurleen Kaur, Thakur Shubham, Kaur Rasdeep, Kaur Satwinderjeet, Sapra Bharti, Singh Pankaj Kumar, Silakari Om

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Energy decomposition and waterswapping analysis to investigate the SNP associated DPD mediated 5-FU resistance (2023)

SAR and QSAR in Environmental Research

Verma Himanshu, Doshi Jinalkumar, Narendra Gera, Raju Baddipadige, Singh Pankaj, Silakari Om

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation (2023)

Journal of Molecular Structure

Singh Manmeet, Verma Himanshu, Bhandu Priyanka, Kumar Manoj, Narendra Gera, Choudhary Shalki, Singh Pankaj Kumar, Silakari Om

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Molecular modeling studies of fused pyrimidine derivatives at various receptors (2023)

Singh Pankaj Kumar

(Vertaisarvioitu artikkeli kokoomateoksessa (A3))

Oxazolidinones: Are they only good for the discovery of antibiotics? A worm's eye view (2023)

Journal of Molecular Structure

Pathania Shelly, Petrova-Szczasiuk Kseniia, Pentikäinen Olli, Singh Pankaj Kumar

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution (2022)

ACS pharmacology & translational science

Verma Himanshu, Narendra Gera, Raju Baddipadige, Singh Pankaj Kumar, Silakari Om

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Identifying novel putative ERK1/2 inhibitors via hybrid scaffold hopping -FBDD approach (2022)

Journal of Biomolecular Structure and Dynamics

Pathania Shelly, Singh Pankaj Kumar, Narang Raj Kumar, Rawal Ravindra K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Hydantoin based dual inhibitors of ALR2 and PARP-1: Design, synthesis, in-vitro and in-vivo evaluation (2022)

Bioorganic Chemistry

Kumar Manoj, Kumar Singh Pankaj, Choudhary Shalki, Silakari Om

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Activin receptor-like kinase-2 inhibitors (2024)

Identification of natural peptides from "PlantPepDB" database as anti-SARS-CoV-2 agents: A protein-protein docking approach (2023)

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach (2023)

Energy decomposition and waterswapping analysis to investigate the SNP associated DPD mediated 5-FU resistance (2023)

Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation (2023)

Molecular modeling studies of fused pyrimidine derivatives at various receptors (2023)

Oxazolidinones: Are they only good for the discovery of antibiotics? A worm's eye view (2023)

Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution (2022)

Identifying novel putative ERK1/2 inhibitors via hybrid scaffold hopping -FBDD approach (2022)

Hydantoin based dual inhibitors of ALR2 and PARP-1: Design, synthesis, in-vitro and in-vivo evaluation (2022)